CD38/CD31 interactions activate genetic pathways leading to proliferation and migration in chronic lymphocytic leukemia cells

Silvia Deaglio, Semra Aydin, Maurizia Mello Grand, Tiziana Vaisitti, Luciana Bergui, Giovanni D'Arena, Giovanna Chiorino, Fabio Malavasi

Research output: Contribution to journalArticle

Abstract

Human CD38 is a pleiotropic glycoprotein belonging to a family of enzymes/receptors involved in the catabolism of extracellular nucleotides. CD38-receptor activities are regulated through binding to the nonsubstrate ligand CD31. CD38 expression above a critical threshold is a negative prognostic marker for chronic lymphocytic leukemia (CLL) patients. Activation of CD38 by means of agonistic monoclonal antibodies or the CD31 ligand induces proliferation and immunoblast differentiation of CLL cells. Here we define the genetic signature that follows long-term in vitrointeractions between CD38 + CLL lymphocytes and CD31+ cells. The emerging profile confirms that the CD31/CD38 axis activates genetic programs relevant for proliferative responses. It also indicates a contribution of this pathway to the processes mediating migration and homing. These results further support the notion that the CD31/CD38 axis is part of a network of accessory signals that modify the microenvironment, favoring localization of leukemic cells to growth-permissive sites.

Original languageEnglish
Pages (from-to)87-91
Number of pages5
JournalMolecular medicine (Cambridge, Mass.)
Volume16
Issue number3-4
DOIs
Publication statusPublished - Mar 2010

Fingerprint

B-Cell Chronic Lymphocytic Leukemia
Ligands
Glycoproteins
Nucleotides
Monoclonal Antibodies
Lymphocytes
Enzymes
Growth

ASJC Scopus subject areas

  • Genetics
  • Molecular Biology
  • Molecular Medicine
  • Genetics(clinical)

Cite this

CD38/CD31 interactions activate genetic pathways leading to proliferation and migration in chronic lymphocytic leukemia cells. / Deaglio, Silvia; Aydin, Semra; Grand, Maurizia Mello; Vaisitti, Tiziana; Bergui, Luciana; D'Arena, Giovanni; Chiorino, Giovanna; Malavasi, Fabio.

In: Molecular medicine (Cambridge, Mass.), Vol. 16, No. 3-4, 03.2010, p. 87-91.

Research output: Contribution to journalArticle

Deaglio, Silvia ; Aydin, Semra ; Grand, Maurizia Mello ; Vaisitti, Tiziana ; Bergui, Luciana ; D'Arena, Giovanni ; Chiorino, Giovanna ; Malavasi, Fabio. / CD38/CD31 interactions activate genetic pathways leading to proliferation and migration in chronic lymphocytic leukemia cells. In: Molecular medicine (Cambridge, Mass.). 2010 ; Vol. 16, No. 3-4. pp. 87-91.
@article{5472be6f7ce74f1296e550b288520ef2,
title = "CD38/CD31 interactions activate genetic pathways leading to proliferation and migration in chronic lymphocytic leukemia cells",
abstract = "Human CD38 is a pleiotropic glycoprotein belonging to a family of enzymes/receptors involved in the catabolism of extracellular nucleotides. CD38-receptor activities are regulated through binding to the nonsubstrate ligand CD31. CD38 expression above a critical threshold is a negative prognostic marker for chronic lymphocytic leukemia (CLL) patients. Activation of CD38 by means of agonistic monoclonal antibodies or the CD31 ligand induces proliferation and immunoblast differentiation of CLL cells. Here we define the genetic signature that follows long-term in vitrointeractions between CD38 + CLL lymphocytes and CD31+ cells. The emerging profile confirms that the CD31/CD38 axis activates genetic programs relevant for proliferative responses. It also indicates a contribution of this pathway to the processes mediating migration and homing. These results further support the notion that the CD31/CD38 axis is part of a network of accessory signals that modify the microenvironment, favoring localization of leukemic cells to growth-permissive sites.",
author = "Silvia Deaglio and Semra Aydin and Grand, {Maurizia Mello} and Tiziana Vaisitti and Luciana Bergui and Giovanni D'Arena and Giovanna Chiorino and Fabio Malavasi",
year = "2010",
month = "3",
doi = "10.2119/molmed.2009.00146",
language = "English",
volume = "16",
pages = "87--91",
journal = "Molecular Medicine",
issn = "1076-1551",
publisher = "Feinstein Institute for Medical Research",
number = "3-4",

}

TY - JOUR

T1 - CD38/CD31 interactions activate genetic pathways leading to proliferation and migration in chronic lymphocytic leukemia cells

AU - Deaglio, Silvia

AU - Aydin, Semra

AU - Grand, Maurizia Mello

AU - Vaisitti, Tiziana

AU - Bergui, Luciana

AU - D'Arena, Giovanni

AU - Chiorino, Giovanna

AU - Malavasi, Fabio

PY - 2010/3

Y1 - 2010/3

N2 - Human CD38 is a pleiotropic glycoprotein belonging to a family of enzymes/receptors involved in the catabolism of extracellular nucleotides. CD38-receptor activities are regulated through binding to the nonsubstrate ligand CD31. CD38 expression above a critical threshold is a negative prognostic marker for chronic lymphocytic leukemia (CLL) patients. Activation of CD38 by means of agonistic monoclonal antibodies or the CD31 ligand induces proliferation and immunoblast differentiation of CLL cells. Here we define the genetic signature that follows long-term in vitrointeractions between CD38 + CLL lymphocytes and CD31+ cells. The emerging profile confirms that the CD31/CD38 axis activates genetic programs relevant for proliferative responses. It also indicates a contribution of this pathway to the processes mediating migration and homing. These results further support the notion that the CD31/CD38 axis is part of a network of accessory signals that modify the microenvironment, favoring localization of leukemic cells to growth-permissive sites.

AB - Human CD38 is a pleiotropic glycoprotein belonging to a family of enzymes/receptors involved in the catabolism of extracellular nucleotides. CD38-receptor activities are regulated through binding to the nonsubstrate ligand CD31. CD38 expression above a critical threshold is a negative prognostic marker for chronic lymphocytic leukemia (CLL) patients. Activation of CD38 by means of agonistic monoclonal antibodies or the CD31 ligand induces proliferation and immunoblast differentiation of CLL cells. Here we define the genetic signature that follows long-term in vitrointeractions between CD38 + CLL lymphocytes and CD31+ cells. The emerging profile confirms that the CD31/CD38 axis activates genetic programs relevant for proliferative responses. It also indicates a contribution of this pathway to the processes mediating migration and homing. These results further support the notion that the CD31/CD38 axis is part of a network of accessory signals that modify the microenvironment, favoring localization of leukemic cells to growth-permissive sites.

UR - http://www.scopus.com/inward/record.url?scp=77649154795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649154795&partnerID=8YFLogxK

U2 - 10.2119/molmed.2009.00146

DO - 10.2119/molmed.2009.00146

M3 - Article

C2 - 19956559

AN - SCOPUS:77649154795

VL - 16

SP - 87

EP - 91

JO - Molecular Medicine

JF - Molecular Medicine

SN - 1076-1551

IS - 3-4

ER -